Biophytis SA
PAR:ALBPS

Watchlist Manager
Biophytis SA Logo
Biophytis SA
PAR:ALBPS
Watchlist
Price: 0.0809 EUR 1%
Market Cap: 3.2m EUR

Net Margin
Biophytis SA

0%
Current
0%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-8m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Biophytis SA
Glance View

Market Cap
3.2m EUR
Industry
Biotechnology

Biophytis SA is a holding company. The company is headquartered in Paris, Ile-De-France and currently employs 24 full-time employees. The company went IPO on 2015-07-13. The firm is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.

ALBPS Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-8m
/
Revenue
0
What is the Net Margin of Biophytis SA?

Based on Biophytis SA's most recent financial statements, the company has Net Margin of 0%.

Back to Top